# Aberdeen Australia Equity Fund, Inc. (NYSE MKT: IAF)
» Closed-End Fund Center
Keep Updated

Daily Data

At close Nov 25, 2014

Market Price$7.46
Unadjusted NAV**$7.85

The NAV information is provided by the Fund's accounting agent. The price is as reported by the exchange on which the Fund trades. This information is unaudited and neither Aberdeen Asset Management PLC, its wholly owned subsidiaries, the Funds, nor any other person guarantees their accuracy.


Request Information

If you require further information on any of our Closed-End Funds:


Email Us





Aberdeen Australia Equity Fund, Inc. (NYSE MKT: IAF)*

Investment Objective

The Fund’s principal investment objective is long-term capital appreciation through investment primarily in equity securities of Australian companies listed on the Australian Stock Exchange Limited (“ASX”). The Fund’s secondary investment objective is current income.

For more detailed information on the specific risks associated with this fund, please view the Important Risk Considerations tab.


Investing in the Asia-Pacific Region

As the West grapples with its debt issues, we believe that the structural soundness of the Asia-Pacific region will help deliver long-term opportunities for investors.

Download brochure

Fund Managers’ Monthly Report

September 2014

  • Australian equities, as measured by the S&P/ASX 200 Index, fell in September—their worst decline since May 2012. Market sentiment was affected by the continued weakness in the commodities sector amid anemic Chinese economic data, while the Australian dollar slid against its strengthening U.S. counterpart.
  • Second-quarter gross domestic product (GDP) suggested a difficult transition towards the non-mining sector. The Reserve Bank of Australia (RBA) appeared to soften its stance on the use of blunt policy tools, such as stricter mortgage rules to calm the frothy property market. The central bank noted that this should enable it to support the rest of the economy, by keeping interest rates low. The RBA subsequently held its benchmark interest rate unchanged.
  • In September, we added to the position in ResMed, which develops and makes medical equipment for sleeprelated and other respiratory disorders. We are encouraged by the success of its recent product launches and its momentum in the U.S. market. Against this, we lowered the Fund’s exposure to diversified miner Rio Tinto, given the dimmer prospects for commodities vis--vis China’s recent economic weakness.
Download Monthly Commentary
Download Monthly Factsheet
Sign Up

To receive this, or any other monthly fund factsheet directly in your inbox, sign up for our email services.

Full investment objective, investment policies and investment restrictions Section 16 Filings


Pursuant to valuation policies adopted by the Board of Directors of the Fund, the Fund values foreign equity securities that primarily trade in certain markets that close ahead of the Fund’s daily 4:00 pm Eastern net asset value (“NAV”) calculation time at their fair values using prices provided by third-party independent pricing services. The fair value of each such security generally is calculated by applying a valuation factor provided by the independent pricing service to the last sales price for that security, or, if, the pricing service is unable to provide a fair value for a security, at the price at the close of the exchange on which it is principally traded, subject to adjustment by the Fund’s Pricing Committee. These daily fair valuations seek to reflect information available after the local market close that may affect the value of the foreign equity securities held by the Fund. As a result, this official NAV calculation reflects adjustments that may cause it to vary from a calculation based solely on closing prices. In contrast, the “Unadjusted NAV” of the Fund (shown above) is for informational purposes only and is computed using the closing prices on the relevant exchange. It does not reflect any daily fair valuation adjustments of the Fund’s foreign securities. The Unadjusted NAV does not represent the official NAV of the Fund, nor is the Unadjusted NAV used for Fund accounting or performance purposes. Investors should not rely upon the Unadjusted NAV when making their investment decisions.

Useful Links